JAMA Forum: Covering the proton beam

As noted last week, Blue Shield of California did something unusual in reversing course and deciding not to cover proton beam therapy for prostate cancer. Will its decision stick or be reversed, the fate of many prior attempts by insurers to control utilization of therapies not clearly superior to cheaper alternatives? I discuss in my new post on the JAMA Forum. Go read it!

@afrakt

Austin Frakt

Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist. His day job is Associate Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs. He is also a Principal Research Scientist with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, and Editor-in-Chief of the journal Health Services Research.

Hidden information below

Austin Frakt

Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist. His day job is Associate Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs. He is also a Principal Research Scientist with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, and Editor-in-Chief of the journal Health Services Research.

The Incidental Economist

the health services research blog

Boston-area website management by BKJ Productions
Editors In Chief
Managing Editor

Work posted here under copyright © of the authors • Details on the Site Policies page

Subscribe

Email Address*